Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]

Detalles Bibliográficos
Autores principales: Guo, Jiwei, Jin, Dan, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Miao, Shuang, Xi, Sichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838040/
https://www.ncbi.nlm.nih.gov/pubmed/33487222
http://dx.doi.org/10.1016/j.ebiom.2020.103168
_version_ 1783643083434360832
author Guo, Jiwei
Jin, Dan
Wu, Yan
Yang, Lijuan
Du, Jing
Gong, Kaikai
Chen, Weiwei
Dai, Juanjuan
Miao, Shuang
Xi, Sichuan
author_facet Guo, Jiwei
Jin, Dan
Wu, Yan
Yang, Lijuan
Du, Jing
Gong, Kaikai
Chen, Weiwei
Dai, Juanjuan
Miao, Shuang
Xi, Sichuan
author_sort Guo, Jiwei
collection PubMed
description
format Online
Article
Text
id pubmed-7838040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78380402021-02-01 Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221] Guo, Jiwei Jin, Dan Wu, Yan Yang, Lijuan Du, Jing Gong, Kaikai Chen, Weiwei Dai, Juanjuan Miao, Shuang Xi, Sichuan EBioMedicine Erratum Elsevier 2021-01-21 /pmc/articles/PMC7838040/ /pubmed/33487222 http://dx.doi.org/10.1016/j.ebiom.2020.103168 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Erratum
Guo, Jiwei
Jin, Dan
Wu, Yan
Yang, Lijuan
Du, Jing
Gong, Kaikai
Chen, Weiwei
Dai, Juanjuan
Miao, Shuang
Xi, Sichuan
Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
title Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
title_full Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
title_fullStr Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
title_full_unstemmed Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
title_short Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
title_sort retraction notice to ‘the mir 495-ube2c-abcg2/ercc1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [ebiomedicine 35 (2018) 204–221]
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838040/
https://www.ncbi.nlm.nih.gov/pubmed/33487222
http://dx.doi.org/10.1016/j.ebiom.2020.103168
work_keys_str_mv AT guojiwei retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT jindan retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT wuyan retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT yanglijuan retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT dujing retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT gongkaikai retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT chenweiwei retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT daijuanjuan retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT miaoshuang retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221
AT xisichuan retractionnoticetothemir495ube2cabcg2ercc1axisreversescisplatinresistancebydownregulatingdrugresistancegenesincisplatinresistantnonsmallcelllungcancercellsebiomedicine352018204221

Ejemplares similares